• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载多西紫杉醇钴铁氧体纳米载体的抗癌潜力: MCF-7 和 MDA-MB-231 细胞系的体外研究。

Anticancer potential of docetaxel-loaded cobalt ferrite nanocarrier: an in vitro study on MCF-7 and MDA-MB-231 cell lines.

机构信息

Department of Physics, Jadavpur University, Kolkata, India.

School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, India.

出版信息

J Microencapsul. 2021 Jan;38(1):36-46. doi: 10.1080/02652048.2020.1842529. Epub 2020 Nov 30.

DOI:10.1080/02652048.2020.1842529
PMID:33206010
Abstract

AIM

To develop a biocompatible cobalt ferrite (CF-NP) nanodrug formulation using oleic acid and poly (d,l-lactide--glycolic) acid (PLGA) for the delivery of docetaxel (DTX) specifically to breast cancer cells.

METHODS

The CF-NP were synthesised by hydrothermal method and conjugated with DTX in a PLGA matrix and were systematically characterised using XRD, FE-SEM, TEM, DLS, FTIR, TGA, SQUID etc. The drug loading, in vitro drug release, cellular uptake, cytotoxicity were evaluated and haemolytic effect was studied.

RESULTS

The CF-NP showed good crystallinity with an average particle size of 21 nm and ferromagnetic nature. The DTX-loaded CF-NP (DCF-NP) showed 8.4% (w/w) drug loading with 81.8% loading efficiency with a sustained DTX release over time. An effective internalisation and anti-proliferative efficiency was observed in MCF-7 and MDA-MB-231 breast cancer cells and negligible haemolytic effect.

CONCLUSION

The DCF-NP can have the potential for the effective delivery of DTX for breast cancer treatment.

摘要

目的

使用油酸和聚(丙交酯-乙交酯)(PLGA)开发一种生物相容性的钴铁氧体(CF-NP)纳米药物制剂,用于将多西他赛(DTX)特异性递送至乳腺癌细胞。

方法

通过水热法合成 CF-NP,并在 PLGA 基质中与 DTX 缀合,使用 XRD、FE-SEM、TEM、DLS、FTIR、TGA、SQUID 等进行系统表征。评估了载药、体外药物释放、细胞摄取、细胞毒性和溶血作用。

结果

CF-NP 具有良好的结晶度,平均粒径为 21nm,具有铁磁性。载多西他赛的 CF-NP(DCF-NP)的载药量为 8.4%(w/w),载药效率为 81.8%,随着时间的推移,DTX 释放呈持续释放。在 MCF-7 和 MDA-MB-231 乳腺癌细胞中观察到有效的内化和抗增殖效率,且溶血作用可忽略不计。

结论

DCF-NP 有可能有效递送至乳腺癌治疗的 DTX。

相似文献

1
Anticancer potential of docetaxel-loaded cobalt ferrite nanocarrier: an in vitro study on MCF-7 and MDA-MB-231 cell lines.载多西紫杉醇钴铁氧体纳米载体的抗癌潜力: MCF-7 和 MDA-MB-231 细胞系的体外研究。
J Microencapsul. 2021 Jan;38(1):36-46. doi: 10.1080/02652048.2020.1842529. Epub 2020 Nov 30.
2
Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells.高分子纳米颗粒的细胞内靶向激活克服了人原发性乳腺癌细胞的化学药物耐药性。
Int J Nanomedicine. 2018 Nov 29;13:8153-8164. doi: 10.2147/IJN.S182184. eCollection 2018.
3
Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.阿那卡酸修饰的自组装白蛋白纳米粒共载多西他赛和吉西他滨用于有效管理乳腺癌。
Acta Biomater. 2018 Jun;73:424-436. doi: 10.1016/j.actbio.2018.03.057. Epub 2018 Apr 9.
4
A zinc ferrite nanodrug carrier for delivery of docetaxel: synthesis, characterization, and tests on C6 glioma cells.载多西紫杉醇的锌铁氧体纳米药物载体的合成、表征及对 C6 神经胶质瘤细胞的作用
J Microencapsul. 2022 Mar;39(2):136-144. doi: 10.1080/02652048.2022.2053757. Epub 2022 Apr 6.
5
Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.载多西紫杉醇的基于 PAMAM 的聚(γ-苄基-L-谷氨酸)-b-d-α-生育酚聚乙二醇 1000 琥珀酸酯纳米粒在人乳腺癌和人宫颈癌治疗中的应用。
J Microencapsul. 2019 Sep;36(6):552-565. doi: 10.1080/02652048.2019.1654002.
6
Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.新型苯乙烯-聚(酰胺-醚-酯-酰亚胺)共聚物胶束的合成、体外表征及其载多西紫杉醇治疗乳腺癌的研究
Drug Dev Ind Pharm. 2018 Jul;44(7):1139-1157. doi: 10.1080/03639045.2018.1438462. Epub 2018 Feb 21.
7
Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles.PLGA/TPGS 纳米粒共递送多西紫杉醇和沙利霉素靶向乳腺癌细胞和干细胞。
Int J Nanomedicine. 2019 Nov 26;14:9199-9216. doi: 10.2147/IJN.S230376. eCollection 2019.
8
Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.载多西他赛的聚乳酸-乙醇酸共聚物纳米粒:制剂、理化特性及细胞毒性研究
J Nanosci Nanotechnol. 2013 Aug;13(8):5948-56. doi: 10.1166/jnn.2013.7735.
9
Formulation of a Sustained Release Docetaxel Loaded Cockle Shell-Derived Calcium Carbonate Nanoparticles against Breast Cancer.载多西紫杉醇的贝壳碳酸钙纳米粒的缓释制剂用于乳腺癌的治疗。
Pharm Res. 2017 Jun;34(6):1193-1203. doi: 10.1007/s11095-017-2135-1. Epub 2017 Apr 5.
10
Development and Characterization of a Fucoidan-Based Drug Delivery System by Using Hydrophilic Anticancer Polysaccharides to Simultaneously Deliver Hydrophobic Anticancer Drugs.基于岩藻聚糖的药物传递系统的开发和表征,利用亲水性抗癌多糖同时传递疏水性抗癌药物。
Biomolecules. 2020 Jun 28;10(7):970. doi: 10.3390/biom10070970.

引用本文的文献

1
Newly Synthesized CoFePrO (y = 0; 0.01; 0.03; 0.05; 0.1; 0.15; 0.2) Nanoparticles Reveal Promising Selective Anticancer Activity Against Melanoma (A375), Breast Cancer (MCF-7), and Colon Cancer (HT-29) Cells.新合成的CoFePrO(y = 0;0.01;0.03;0.05;0.1;0.15;0.2)纳米颗粒对黑色素瘤(A375)、乳腺癌(MCF-7)和结肠癌(HT-29)细胞显示出有前景的选择性抗癌活性。
Nanomaterials (Basel). 2025 May 30;15(11):829. doi: 10.3390/nano15110829.
2
Conveyance of sofosbuvir through vesicular lipid nanocarriers as an effective strategy for management of viral meningitis.索磷布韦通过囊泡脂质纳米载体的转运作为治疗病毒性脑膜炎的有效策略。
RSC Adv. 2023 Nov 15;13(47):33500-33513. doi: 10.1039/d3ra06540e. eCollection 2023 Nov 7.
3
Newly Synthesized CoFeDyO (x = 0; 0.1; 0.2; 0.4) Nanoparticles Reveal Promising Anticancer Activity against Melanoma (A375) and Breast Cancer (MCF-7) Cells.
新合成的 CoFeDyO(x = 0;0.1;0.2;0.4)纳米粒子对黑色素瘤(A375)和乳腺癌(MCF-7)细胞表现出有希望的抗癌活性。
Int J Mol Sci. 2023 Oct 29;24(21):15733. doi: 10.3390/ijms242115733.